Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.250
-0.920 (-22.06%)
At close: Jun 23, 2025, 4:00 PM
2.950
-0.300 (-9.23%)
Pre-market: Jun 24, 2025, 6:12 AM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $12.04 million as of June 24, 2025. Its market cap has increased by 264.98% in one year.
Market Cap
12.04M
Enterprise Value
14.33M
1-Year Change
264.98%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $12.04M, a decrease of -92.50%. That is a compound annual growth rate of -25.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 1.70M | -22.73% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.46B |
| Johnson & Johnson | 361.63B |
| Novo Nordisk | 326.28B |
| AbbVie | 323.20B |
| UnitedHealth Group | 269.87B |
| Abbott Laboratories | 229.92B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |